Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista colombiana de Gastroenterología
Print version ISSN 0120-9957
Abstract
REYES M, Gustavo Adolfo; CARVAJAL P, Germán David; TAPIAS M, Mónica Lorena and SABBAGH S, Luis Carlos. Hepatotoxicity due to Isoniazide in a Patient with Crohn’s Disease: Case Report and Literature Review. Rev Col Gastroenterol [online]. 2016, vol.31, n.4, pp.438-442. ISSN 0120-9957.
Isoniazid is used for treatment or prophylaxis of tuberculosis but may be associated with adverse hepatic reactions. Clinically manifest hepatitis occurs in 0.5%-1% of patients who receive isoniazid as monotherapy. This article describes the case of a patient with Crohn’s disease who experienced severe hepatotoxicity due to isoniazid. It also reviews the literature.
Keywords : Isoniazid; hepatotoxicity; DILI (idiosyncratic drug-induced liver injury); Crohn’s disease.